High expression of MAP7 predicts adverse prognosis in young patients with cytogenetically normal acute myeloid leukemia
Citations Over TimeTop 17% of 2016 papers
Abstract
Microtubule-associated protein 7 (MAP7) plays an important role in cancer cells. In this study, we identified the prognostic significance of MAP7 expression in cytogenetically normal acute myeloid leukemia (CN-AML) patients (aged high) was associated with adverse overall survival (OS; P = 0.0441) and event-free survival (EFS; P = 0.0114) compared with low MAP7 expression (MAP7low). In addition, the prognostic significance of MAP7 was confirmed by European Leukemia Net (ELN) intermediate-I genetic categories and multivariable analysis. In the second independent group of CN-AML patients (aged high was also associated with adverse OS (n = 88, OS; P = 0.00811). To understand the inherent mechanisms of MAP7's prognosis, we investigated genome-wide gene/microRNA expression signatures associated with MAP7 expression. Several known oncogenic genes/microRNAs and anti-oncogenic genes/microRNAs were disordered in MAP7high CN-AML patients. In conclusion, MAP7high is an adverse prognostic biomarker for CN-AML, which may be attributed to the distinctive genome-wide gene/microRNA expression and related cell signaling pathways.
Related Papers
- → Clinical relevance vs. statistical significance: Using neck outcomes in patients with temporomandibular disorders as an example(2011)166 cited
- → Resonance Raman spectroscopic evaluation of skin carotenoids as a biomarker of carotenoid status for human studies(2013)110 cited
- → Supporting evidence for using biomarkers in the diagnosis of MCI due to AD(2012)55 cited
- → P2‐215: Supporting evidence of the Alzheimer's disease biomarker dynamic model in patients with mild cognitive impairment(2012)1 cited
- → P4‐123: Resolving Conflicting CSF Biomarker Information in Alzheimer′s Disease(2016)